Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Work by Bailey and Dynarski cited in NYT piece on income inequality

Pfeffer says housing bubble masked decade-long growth in household net worth inequality

House, Burgard, Schoeni et al find that unemployment and recession have contrasting effects on mortality risk

Highlights

Jeff Morenoff makes Reuters' Highly Cited Researchers list for 2014

Susan Murphy named Distinguished University Professor

Sarah Burgard and former PSC trainee Jennifer Ailshire win ASA award for paper

James Jackson to be appointed to NSF's National Science Board

Next Brown Bag


PSC Brown Bags will return in the fall

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression

Archived Abstract of Former PSC Researcher

Katon, W., J. Unutzer, M.Y. Fan, J.W. Williamn, Michael Schoenbaum, E. H B Lin, and E.M. Hunkeler. 2006. "Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression." Diabetes Care, 29(2): 265-270.

OBJECTIVE - To determine the incremental cost-effectiveness and net benefit of a depression collaborative care program compared with usual care for patients with diabetes and depression. RESEARCH DESIGN AND METHODS - This article describes a preplanned subgroup analysis of patients with diabetes from the Improving Mood-Promoting Access to Collaborative (IMPACT) randomized controlled trial. The setting for the study included 18 primary care clinics from eight health care organizations in five states. A total of 418 of 1,801 patients randomized to the IMPACT intervention (n = 204) versus usual care (n = 214) had coexisting diabetes. A depression care manager offered education, behavioral activation, and a choice of problem-solving treatment or support of antidepressant management by the primary care physician. The main outcomes were incremental cost-effectiveness and net benefit of the program compared with usual care. RESULTS - Relative to usual care, intervention patients experienced 115 (95% CI 72 - 159) more depression-free days over 24 months. Total outpatient costs were $25 (95% CI - 1,638 to 1,689) higher during this same period. The incremental cost per depression-free day was 25 cents (-$14 to $15) and the incremental cost per quality-aqjusted life year ranged from $198 . (144-316) to $397 (287 - 641). An incremental net benefit of $1,129 (692 - 1,572) was found. CONCLUSIONS - The IMPACT intervention is a high-value investment for older adults with diabetes; it is associated with high clinical benefits at no greater cost than usual care.

DOI:10.2337/diacare.29.02.06.dc05-1572 (Full Text)

Browse | Search : All Pubs | Next